Amylyx Pharmaceuticals (AMLX) Return on Sales (2021 - 2025)
Amylyx Pharmaceuticals (AMLX) posted quarterly Return on Sales of 1.36% for Q3 2025, up 310.0% year-over-year from 0.33% in Q3 2024, and down 76.05% quarter-over-quarter from 5.66% in Q2 2025.
Amylyx Pharmaceuticals (AMLX) Return on Sales (2021 - 2025) Analysis & Trends
Amylyx Pharmaceuticals' Return on Sales history runs 5 years deep, the most recent figure standing at 1.36% for Q3 2025.
- In Q3 2025, Return on Sales rose 310.0% year-over-year to 1.36%; the TTM figure through Sep 2025 stood at 1.36% (up 137.0% YoY), while the FY2024 annual figure was 0.03%, down 3.0% from the prior year.
- Return on Sales for Q3 2025 stood at 1.36%, down from 5.66% in the prior quarter.
- The five-year high for Return on Sales was 5.66% in Q2 2025, with the low at 1.94% in Q1 2025.
- The 5-year median for Return on Sales is 0.02% (2022), against an average of 0.01%.
- Peak annual rise in Return on Sales reached 637 bps in 2025, while the deepest fall reached 193 bps in 2025.
- Amylyx Pharmaceuticals' Return on Sales stood at 0.81% in 2021, then jumped by 98 bps to 0.02% in 2022, then soared by 101 bps to 0.0% in 2023, then tumbled by 161386 bps to 0.4% in 2024, then surged by 438 bps to 1.36% in 2025.
- Business Quant data shows AMLX's Return on Sales at 1.36% in Q3 2025, 5.66% in Q2 2025, and 1.94% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.64 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.74 Bn | 22.95 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.26 Bn | 19.60 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 12.15 Bn | 11.62 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.30 Bn | 4.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.36% |
| Jun 30, 2025 | 5.66% |
| Mar 31, 2025 | -1.94% |
| Dec 31, 2024 | -0.40% |
| Sep 30, 2024 | -1.75% |
| Jun 30, 2024 | -0.71% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -1.56% |
| Sep 30, 2021 | -0.81% |